Laurus Labs shares surge 6% after US approves ’emergency humanitarian waiver’ for HIV treatment

Share it

Laurus Labs said that the overall Anti-Retro Viral (ARV) market size is $1.5 billion, which is 10% of the total HIV financing budget annually.

Leave a Comment

Your email address will not be published. Required fields are marked *